Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$54,073
-$260,287 QoQ
Shares Held
428
-91.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,052
of 2,266 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFG Advisory, LLC holds $39,371,083 across 16 Drug Manufacturers - General names. GILD ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
42,985 | $10,816,745 | |
| 2 | JNJ |
Johnson & Johnson
|
39,578 | $10,051,624 | |
| 3 | LLY |
ELI LILLY & Co
|
4,333 | $5,197,130 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
64,156 | $3,696,668 | |
| 5 | AMGN |
Amgen Inc
|
9,053 | $3,278,272 | |
| 6 | MRK |
Merck & Co., Inc.
|
20,458 | $2,628,853 | |
| 7 | PFE |
Pfizer Inc
|
39,164 | $943,069 | |
| 8 | GSK |
GSK plc
|
16,758 | $878,454 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,073 | 428 | Shares | Sole | 2026-08-14 | |
| 2021-03-31 | $314,360 | 4,864 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $221,388 | 3,800 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $217,815 | 3,447 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $268,905 | 3,495 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $258,520 | 3,458 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||